Henkes Hans, Bhogal Pervinder, Aguilar Pérez Marta, Lenz-Habijan Tim, Bannewitz Catrin, Peters Marcus, Sengstock Christina, Ganslandt Oliver, Lylyk Pedro, Monstadt Hermann
Neuroradiological Clinic, Klinikum Stuttgart, Stuttgart, Germany.
Medical Faculty, University Duisburg-Essen, Essen, Germany.
Interv Neuroradiol. 2019 Dec;25(6):619-627. doi: 10.1177/1591019919858000. Epub 2019 Jun 27.
Stent-assisted coiling and extra-saccular flow diversion require dual anti-platelet therapy due to the thrombogenic properties of the implants. While both methods are widely accepted, thromboembolic complications and the detrimental effects of dual anti-platelet therapy remain a concern. Anti-thrombogenic surface coatings aim to solve both of these issues. Current developments are discussed within the framework of an actual clinical case.
A 33-year-old male patient lost consciousness while doing sport and was administered 500 mg acetylsalicylic acid on site. Computed tomography revealed a massive subarachnoid haemorrhage, and digital subtraction angiography showed an aneurysm of the right middle cerebral artery. Stent-assisted coiling using a neck bridging device with a hydrophilic coating (pCONUS_HPC) was considered as an appropriate approach. Another 500 mg acetylsalicylic acid IV was given. After the single anti-platelet therapy was seen to be effective, a pCONUS_HPC was implanted, and the aneurysm sac subsequently fully occluded using coils. No thrombus formation was encountered. During the following days, 2 × 500 mg acetylsalicylic acid IV daily were required to maintain single anti-platelet therapy, monitored by frequent response testing. Follow-up digital subtraction angiography after 13 days confirmed the occlusion of the aneurysm and the patency of the middle cerebral artery.
A variety of ways to reduce the thrombogenicity of neurovascular stents is discussed. Hydrophilic surface coatings are a valid concept to improve the haemocompatibility of neurovascular implants while avoiding the use of dual anti-platelet therapy. Phosphorylcholine and phenox hydrophilic polymer coating are currently the most promising candidates. This concept is supported by anecdotal experience. However, formalised registries and randomised trials are currently being established.
由于植入物具有致血栓形成特性,支架辅助弹簧圈栓塞术和囊外血流导向术需要双重抗血小板治疗。虽然这两种方法都被广泛接受,但血栓栓塞并发症和双重抗血小板治疗的有害影响仍然令人担忧。抗血栓形成表面涂层旨在解决这两个问题。本文在一个实际临床病例的框架内讨论了当前的进展。
一名33岁男性患者在运动时失去意识,现场给予500mg阿司匹林。计算机断层扫描显示大量蛛网膜下腔出血,数字减影血管造影显示右侧大脑中动脉动脉瘤。使用具有亲水涂层的颈部桥接装置(pCONUS_HPC)进行支架辅助弹簧圈栓塞术被认为是一种合适的方法。又静脉注射了500mg阿司匹林。在单一抗血小板治疗被证明有效后,植入了pCONUS_HPC,随后使用弹簧圈使动脉瘤囊完全闭塞。未发现血栓形成。在接下来的几天里,每天需要静脉注射2×500mg阿司匹林以维持单一抗血小板治疗,并通过频繁的反应测试进行监测。13天后的随访数字减影血管造影证实动脉瘤闭塞,大脑中动脉通畅。
讨论了多种降低神经血管支架血栓形成性的方法。亲水表面涂层是提高神经血管植入物血液相容性同时避免使用双重抗血小板治疗的有效概念。磷酰胆碱和苯氧基亲水聚合物涂层目前是最有前景的候选者。这一概念得到了轶事经验的支持。然而,目前正在建立正式的登记处和随机试验。